The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
Open accessAbstract
Purpose: To provide an update on recent advances in the management of patients with multiple myeloma who are not eligible for autologous stem-cell transplantation. Methods: A comprehensive review of the literature on diagnostic criteria is provided, and treatment options and management of adverse events are summarized. Results: Patients with symptomatic disease and organ damage (ie, hypercalcemia, renal failure, anemia, or bone lesions) require immediate treatment. The International Staging System and chromosomal abnormalities identify high- and standard-risk patients. Proteasome inhibitors, immunomodulatory drugs, corticosteroids, and alkylating agents are the most active agents. The presence of concomitant diseases, frailty, or disability should be assessed and, if present, treated with reduced-dose approaches. Bone disease, renal damage, hematologic toxicities, infections, thromboembolism, and peripheral neuropathy are the most frequent disabling events requiring prompt and active supportive care. Conclusion: These recommendations will help clinicians ensure the most appropriate care for patients with myeloma in everyday clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
International Staging System for Multiple Myeloma
Greipp, P. R., Miguel, J. S., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Avet-Loiseau, H., Kyle, R. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.242 · Cited by 2,974
Self-citationInternational uniform response criteria for multiple myeloma
Durie, B. G. M., Harousseau, J.-L., Miguel, J. S., Bladé, J., Barlogie, B., Anderson, K., Gertz, M., Dimopoulos, M., Westin, J., Sonneveld, P., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404284 · Cited by 2,632
Self-citationSEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043445 · Cited by 2,491
Self-citationBortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Self-citationBladÉ, J., Samson, D., Reece, D., Apperley, J., BJÖrkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S., Vesole, D., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00930.x · Cited by 1,519
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J.-L., Dmoszynska, A., Miguel, J. S., Hellmann, A., Facon, T., Foà, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070594 · Cited by 1,450
Self-citationKyle, R. A., & Rajkumar, S. V. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041875 · Cited by 1,296
Self-citationLenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Weber, D. M., Chen, C., Niesvizky, R., Wang, M., Belch, A., Stadtmauer, E. A., Siegel, D., Borrello, I., Rajkumar, S. V., Chanan-Khan, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070596 · Cited by 1,233
Self-citationCriteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
Kyle, R. A., & Rajkumar, S. V. (2009) · Leukemia · doi:10.1038/leu.2008.291 · Cited by 1,121
Self-citationRajkumar, S. V., Harousseau, J.-L., Durie, B., Anderson, K. C., Dimopoulos, M., Kyle, R., Blade, J., Richardson, P., Orlowski, R., Siegel, D., et al. (2011) · Blood · doi:10.1182/blood-2010-10-299487 · Cited by 1,036
Self-citationRajkumar, S. V., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S., Katz, M., & Greipp, P. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70284-0 · Cited by 933 · cited 4×
“The most common grade 3 AEs were thrombosis, infections, and fatigue and were more frequent with RD.(42)”
BackgroundInfluentialSelf-citationMoreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., Grishunina, M., Rekhtman, G., Masliak, Z., Robak, T., Shubina, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70081-x · Cited by 920
Self-citationShaughnessy, J. D., Zhan, F., Burington, B. E., Huang, Y., Colla, S., Hanamura, I., Stewart, J. P., Kordsmeier, B., Randolph, C., Williams, D. R., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038430 · Cited by 914
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Fonseca, R., Bergsagel, P. L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A. K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.174 · Cited by 886
Self-citationRosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A., Mackey, J., Apffelstaedt, J., Hussein, M. A., Coleman, R. E., Reitsma, D. J., et al. (2003) · Cancer · doi:10.1002/cncr.11701 · Cited by 873
Facon, T., Mary, J. Y., Hulin, C., Benboubker, L., Attal, M., Pegourie, B., Renaud, M., Harousseau, J. L., Guillerm, G., Chaleteix, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61537-2 · Cited by 869
Rajkumar, S. V., Blood, E., Vesole, D., Fonseca, R., & Greipp, P. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0221 · Cited by 865
Self-citationRichardson, P. G., Weller, E., Lonial, S., Jakubowiak, A. J., Jagannath, S., Raje, N. S., Avigan, D. E., Xie, W., Ghobrial, I. M., Schlossman, R. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268862 · Cited by 861
Self-citationPrevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
Self-citationDispenzieri, A., Kyle, R., Merlini, G., Miguel, J. S., Ludwig, H., Hajek, R., Palumbo, A., Jagannath, S., Blade, J., Lonial, S., et al. (2009) · Leukemia · doi:10.1038/leu.2008.307 · Cited by 815
Self-citationPalumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 809
Self-citationContinuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112704 · Cited by 741
Self-citationKumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., et al. (2012) · Leukemia · doi:10.1038/leu.2011.196 · Cited by 721
Self-citationSiegel, D. S., Martin, T., Wang, M., Vij, R., Jakubowiak, A. J., Lonial, S., Trudel, S., Kukreti, V., Bahlis, N., Alsina, M., et al. (2012) · Blood · doi:10.1182/blood-2012-05-425934 · Cited by 657
Self-citationRichardson, P. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D. S., Irwin, D., Schuster, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 649
Self-citationOrlowski, R. Z., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., San Miguel, J., Robak, T., Dmoszynska, A., Horvath, N., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5460 · Cited by 645
Self-citationMorgan, G. J., Davies, F. E., Gregory, W. M., Cocks, K., Bell, S. E., Szubert, A. J., Navarro-Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62051-x · Cited by 575
Self-citationBerenson, J. R., Hillner, B. E., Kyle, R. A., Anderson, K., Lipton, A., Yee, G. C., & Biermann, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.037 · Cited by 542
Self-citationZamagni, E., Patriarca, F., Nanni, C., Zannetti, B., Englaro, E., Pezzi, A., Tacchetti, P., Buttignol, S., Perrone, G., Brioli, A., et al. (2011) · Blood · doi:10.1182/blood-2011-06-361386 · Cited by 531
Self-citationRichardson, P. G., Blood, E., Mitsiades, C. S., Jagannath, S., Zeldenrust, S. R., Alsina, M., Schlossman, R. L., Rajkumar, S. V., Desikan, K. R., Hideshima, T., et al. (2006) · Blood · doi:10.1182/blood-2006-04-015909 · Cited by 523
Self-citationAugustson, B. M., Begum, G., Dunn, J. A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J. A., & Drayson, M. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2086 · Cited by 488
Self-citationMateos, M.-V., Oriol, A., Martínez-López, J., Gutiérrez, N., Teruel, A.-I., de Paz, R., García-Laraña, J., Bengoechea, E., Martín, A., Mediavilla, J. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70187-x · Cited by 458
Self-citationDimopoulos, M., Kyle, R., Fermand, J.-P., Rajkumar, S. V., San Miguel, J., Chanan-Khan, A., Ludwig, H., Joshua, D., Mehta, J., Gertz, M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-299529 · Cited by 454
Self-citationMateos, M.-V., Richardson, P. G., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0638 · Cited by 433
Self-citationPalumbo, A., Bringhen, S., Rossi, D., Cavalli, M., Larocca, A., Ria, R., Offidani, M., Patriarca, F., Nozzoli, C., Guglielmelli, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.8216 · Cited by 423 · cited 1×
“The four-drug combination of bortezomib, melphalan, prednisone, and thalidomide followed by continuous bortezomibthalidomide (VMPT-VT) demonstrated better responses and a PFS prolongation of 8 months compared with VMP, but the efficacy advantage was mainly reported in fit patients 65 to 75 years of age.(36,37) Bortezo…”
MethodSelf-citationMulligan, G., Mitsiades, C., Bryant, B., Zhan, F., Chng, W. J., Roels, S., Koenig, E., Fergus, A., Huang, Y., Richardson, P., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044974 · Cited by 416
Self-citationDimopoulos, M. A., Terpos, E., Chanan-Khan, A., Leung, N., Ludwig, H., Jagannath, S., Niesvizky, R., Giralt, S., Fermand, J.-P., Bladé, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.8791 · Cited by 414
Self-citationKyle, R. A., Yee, G. C., Somerfield, M. R., Flynn, P. J., Halabi, S., Jagannath, S., Orlowski, R. Z., Roodman, D. G., Twilde, P., & Anderson, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1269 · Cited by 409
Self-citationDispenzieri, A., Katzmann, J. A., Kyle, R. A., Larson, D. R., Melton, L. J., Colby, C. L., Therneau, T. M., Clark, R., Kumar, S. K., Bradwell, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60482-5 · Cited by 394
Self-citationEfficacy and safety of once-weekly bortezomib in multiple myeloma patients
Bringhen, S., Larocca, A., Rossi, D., Cavalli, M., Genuardi, M., Ria, R., Gentili, S., Patriarca, F., Nozzoli, C., Levi, A., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294983 · Cited by 381
Self-citationHulin, C., Facon, T., Rodon, P., Pegourie, B., Benboubker, L., Doyen, C., Dib, M., Guillerm, G., Salles, B., Eschard, J.-P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0948 · Cited by 381
Self-citationReeder, C. B., Reece, D. E., Kukreti, V, Chen, C., Trudel, S., Hentz, J., Noble, B., Pirooz, N. A., Spong, J. E., Piza, J. G., et al. (2009) · Leukemia · doi:10.1038/leu.2009.26 · Cited by 372
Self-citationPrimary dexamethasone treatment of multiple myeloma
Alexanian, R., Dimopoulos, M., Delasalle, K., & Barlogie, B. (1992) · Blood · doi:10.1182/blood.v80.4.887.887 · Cited by 366
Self-citationZamagni, E., Nanni, C., Patriarca, F., Englaro, E., Castellucci, P., Geatti, O., Tosi, P., Tacchetti, P., Cangini, D., Perrone, G., et al. (2007) · Haematologica · doi:10.3324/haematol.10554 · Cited by 354
Self-citationPalumbo, A., Bringhen, S., Ludwig, H., Dimopoulos, M. A., Bladé, J., Mateos, M. V., Rosiñol, L., Boccadoro, M., Cavo, M., Lokhorst, H., et al. (2011) · Blood · doi:10.1182/blood-2011-06-358812 · Cited by 352
Self-citationInfections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
Nucci, M., & Anaissie, E. (2009) · Clinical Infectious Diseases · doi:10.1086/605664 · Cited by 347
Rajkumar, S. V., Rosiñol, L., Hussein, M., Catalano, J., Jedrzejczak, W., Lucy, L., Olesnyckyj, M., Yu, Z., Knight, R., Zeldis, J. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1853 · Cited by 343
Self-citationMorgan, G. J., Gregory, W. M., Davies, F. E., Bell, S. E., Szubert, A. J., Brown, J. M., Coy, N. N., Cook, G., Russell, N. H., Rudin, C., et al. (2012) · Blood · doi:10.1182/blood-2011-06-357038 · Cited by 331
Self-citationPalumbo, A. (2004) · Blood · doi:10.1182/blood-2004-02-0408 · Cited by 329
Self-citationPalumbo, A., Cavo, M., Bringhen, S., Zamagni, E., Romano, A., Patriarca, F., Rossi, D., Gentilini, F., Crippa, C., Galli, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6844 · Cited by 323
Self-citationRoss, F. M., Avet-Loiseau, H., Ameye, G., Gutierrez, N. C., Liebisch, P., O'Connor, S., Dalva, K., Fabris, S., Testi, A. M., Jarosova, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.056176 · Cited by 322
Self-citationCaraceni, A., Zecca, E., Bonezzi, C., Arcuri, E., Tur, R. Y., Maltoni, M., Visentin, M., Gorni, G., Martini, C., Tirelli, W., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.141 · Cited by 319
Cavo, M., Rajkumar, S. V., Palumbo, A., Moreau, P., Orlowski, R., Bladé, J., Sezer, O., Ludwig, H., Dimopoulos, M. A., Attal, M., et al. (2011) · Blood · doi:10.1182/blood-2011-02-297325 · Cited by 314
Self-citationMunshi, N. C., Anderson, K. C., Bergsagel, P. L., Shaughnessy, J., Palumbo, A., Durie, B., Fonseca, R., Stewart, A. K., Harousseau, J.-L., Dimopoulos, M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-300970 · Cited by 311
Self-citationGuidelines for the diagnosis and management of multiple myeloma 2011
Bird, J. M., Owen, R. G., D’Sa, S., Snowden, J. A., Pratt, G., Ashcroft, J., Yong, K., Cook, G., Feyler, S., Davies, F., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08573.x · Cited by 306
Self-citationRizzo, J. D., Brouwers, M., Hurley, P., Seidenfeld, J., Arcasoy, M. O., Spivak, J. L., Bennett, C. L., Bohlius, J., Evanchuk, D., Goode, M. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2201 · Cited by 303
Larocca, A., Cavallo, F., Bringhen, S., Di Raimondo, F., Falanga, A., Evangelista, A., Cavalli, M., Stanevsky, A., Corradini, P., Pezzatti, S., et al. (2012) · Blood · doi:10.1182/blood-2011-03-344333 · Cited by 288
Self-citationSerum test for assessment of patients with Bence Jones myeloma
Bradwell, A. R., Carr-Smith, H. D., Mead, G. P., Harvey, T. C., & Drayson, M. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12457-9 · Cited by 285
Fayers, P. M., Palumbo, A., Hulin, C., Waage, A., Wijermans, P., Beksaç, M., Bringhen, S., Mary, J.-Y., Gimsing, P., Termorshuizen, F., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341669 · Cited by 272
Self-citationGay, F., Larocca, A., Wijermans, P., Cavallo, F., Rossi, D., Schaafsma, R., Genuardi, M., Romano, A., Liberati, A. M., Siniscalchi, A., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307645 · Cited by 263
Self-citationWijermans, P., Schaafsma, M., Termorshuizen, F., Ammerlaan, R., Wittebol, S., Sinnige, H., Zweegman, S., van Marwijk Kooy, M., van der Griend, R., Lokhorst, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1610 · Cited by 260
Self-citationManagement of treatment-emergent peripheral neuropathy in multiple myeloma
Richardson, P. G., Delforge, M., Beksac, M., Wen, P., Jongen, J. L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S. V., et al. (2012) · Leukemia · doi:10.1038/leu.2011.346 · Cited by 253
Self-citationChemotherapy-induced peripheral neurotoxicity
Cavaletti, G., & Marmiroli, P. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000234 · Cited by 239
Myeloma bone disease: pathophysiology and management
Terpos, E., & Dimopoulos, M.-A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi235 · Cited by 235
Self-citationMelphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
Waage, A., Gimsing, P., Fayers, P., Abildgaard, N., Ahlberg, L., Björkstrand, B., Carlson, K., Dahl, I. M., Forsberg, K., Gulbrandsen, N., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237974 · Cited by 230
Terpos, E., Sezer, O., Croucher, P. I., García-Sanz, R., Boccadoro, M., San Miguel, J., Ashcroft, J., Bladé, J., Cavo, M., Delforge, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn796 · Cited by 230
Self-citationMayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma
Lacy, M. Q., Dispenzieri, A., Gertz, M. A., Greipp, P. R., Gollbach, K. L., Hayman, S. R., Kumar, S., Lust, J. A., Rajkumar, S. V., Russell, S. J., et al. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.8.1047 · Cited by 228
Self-citationJagannath, S., Barlogie, B., Berenson, J. R., Singhal, S., Alexanian, R., Srkalovic, G., Orlowski, R. Z., Richardson, P. G., Anderson, J., Nix, D., et al. (2005) · Cancer · doi:10.1002/cncr.20888 · Cited by 222
Self-citationLudwig, H., Hajek, R., Tóthová, E., Drach, J., Adam, Z., Labar, B., Egyed, M., Spicka, I., Gisslinger, H., Greil, R., et al. (2009) · Blood · doi:10.1182/blood-2008-07-169565 · Cited by 208
Self-citationGuidelines for supportive care in multiple myeloma 2011
Snowden, J. A., Ahmedzai, S. H., Ashcroft, J., D’Sa, S., Littlewood, T., Low, E., Lucraft, H., Maclean, R., Feyler, S., Pratt, G., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08574.x · Cited by 206
Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
Martinez-Lopez, J., Blade, J., Mateos, M.-V., Grande, C., Alegre, A., García-Laraña, J., Sureda, A., de la Rubia, J., Conde, E., Martinez, R., et al. (2011) · Blood · doi:10.1182/blood-2011-01-332320 · Cited by 206
Self-citationMorgan, G. J., Davies, F. E., Gregory, W. M., Russell, N. H., Bell, S. E., Szubert, A. J., Coy, N. N., Cook, G., Feyler, S., Byrne, J. L., et al. (2011) · Blood · doi:10.1182/blood-2011-02-338665 · Cited by 198
Self-citationIMWG consensus on maintenance therapy in multiple myeloma
Ludwig, H., Durie, B. G. M., McCarthy, P., Palumbo, A., San Miguel, J., Barlogie, B., Morgan, G., Sonneveld, P., Spencer, A., Andersen, K. C., et al. (2012) · Blood · doi:10.1182/blood-2011-11-374249 · Cited by 193
Self-citationReeder, C. B., Reece, D. E., Kukreti, V., Chen, C., Trudel, S., Laumann, K., Hentz, J., Pirooz, N. A., Piza, J. G., Tiedemann, R., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271676 · Cited by 190
Self-citationSan-Miguel, J. F., Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405087 · Cited by 185
Self-citationAvet-Loiseau, H., Durie, B. G. M., Cavo, M., Attal, M., Gutierrez, N., Haessler, J., Goldschmidt, H., Hajek, R., Lee, J. H., Sezer, O., et al. (2013) · Leukemia · doi:10.1038/leu.2012.282 · Cited by 181
Self-citationWang, M., Dimopoulos, M. A., Chen, C., Cibeira, M. T., Attal, M., Spencer, A., Rajkumar, S. V., Yu, Z., Olesnyckyj, M., Zeldis, J. B., et al. (2008) · Blood · doi:10.1182/blood-2008-02-141614 · Cited by 176 · cited 1×
“Reexposure to immunomodulatory drugs such as lenalidomide after previous thalidomide seems feasible; however, efficacy and survival may be lower.(75,76) In case of stable disease without CRAB symptoms, the treatment strategy should not be changed.”
BackgroundSelf-citationDiagnosis of Smoldering Multiple Myeloma
Rajkumar, S. V., Larson, D., & Kyle, R. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1106428 · Cited by 176
Self-citationPalumbo, A., Gay, F., Falco, P., Crippa, C., Montefusco, V., Patriarca, F., Rossini, F., Caltagirone, S., Benevolo, G., Pescosta, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7561 · Cited by 173
Self-citationSrkalovic, G., Cameron, M. G., Rybicki, L., Deitcher, S. R., Kattke‐Marchant, K., & Hussein, M. A. (2004) · Cancer · doi:10.1002/cncr.20405 · Cited by 172
Dimopoulos, M. A., Richardson, P. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kastritis, E., Kropff, M., Petrucci, M. T., Delforge, M., Alexeeva, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.2232 · Cited by 172
Self-citationSnozek, C. L. H., Katzmann, J. A., Kyle, R. A., Dispenzieri, A., Larson, D. R., Therneau, T. M., Melton, L. J., Kumar, S., Greipp, P. R., Clark, R. J., et al. (2008) · Leukemia · doi:10.1038/leu.2008.171 · Cited by 168
Self-citationPalumbo, A. P., Sezer, O., Kyle, R. A., Miguel, J. F. S., Orlowski, R. Z., Moreau, P., Niesvizky, R., Morgan, G. J., Comenzo, R. L., Sonneveld, P., et al. (2009) · Leukemia · doi:10.1038/leu.2009.122 · Cited by 166
Self-citationMorgan, G. J., Child, J. A., Gregory, W. M., Szubert, A. J., Cocks, K., Bell, S. E., Navarro-Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70157-7 · Cited by 165
Self-citationBohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M. J., Weingart, O., Kluge, S., et al. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007303.pub2 · Cited by 155
Keskinbora, K., Pekel, A. F., & Aydınlı, I. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.11.013 · Cited by 152
Zonder, J. A., Barlogie, B., Durie, B. G. M., McCoy, J., Crowley, J. J., & Hussein, M. A. (2006) · Blood · doi:10.1182/blood-2006-01-0154 · Cited by 146
Self-citationMultiple myeloma: 2012 update on diagnosis, risk-stratification, and management
Rajkumar, S. V. (2012) · American Journal of Hematology · doi:10.1002/ajh.22237 · Cited by 144
Self-citationBeksaç, M., Haznedar, R., Firatli‐Tuglular, T., Özdoğu, H., Aydoğdu, İ., Konuk, N., Sucak, G. T., Kaygusuz, I., Karakuş, S., Kaya, E., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01524.x · Cited by 143
Mateos, M., Oriol, A., Martínez‐López, J., Gutierrez, N. C., Teruel, A. I., de la Guía, A. L., López, J., Bengoechea, E., Pérez, M., Polo, M., et al. (2012) · Blood · doi:10.1182/blood-2012-05-427815 · Cited by 143
Dimopoulos, M. A., Alegre, A. M., Stadtmauer, E. A., Goldschmidt, H., Zonder, J. A., de Castro, C. M., Masliak, Z., Reece, D. E., Olesnyckyj, M., Yu, Z., et al. (2010) · Cancer · doi:10.1002/cncr.25139 · Cited by 137
Self-citationRajkumar, S. V., Harousseau, J., Durie, B. G. M., Anderson, K. C., Dimopoulos, M. A., Kyle, R. A., Bladé, J., Richardson, P. G. G., Orlowski, R. Z., Siegel, D. S. D., et al. (2011) · Institutional Research Information System University of Turin (University of Turin) · Cited by 131
Self-citationDimopoulos, M. A., Kastritis, E., Christoulas, D., Migkou, M., Gavriatopoulou, M., Gkotzamanidou, M. A., Iakovaki, M., Matsouka, C., Mparmparoussi, D., Ρούσσου, Μ., et al. (2010) · Leukemia · doi:10.1038/leu.2010.175 · Cited by 125
Self-citationBirgegård, G., Gascón, P., & Ludwig, H. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00739.x · Cited by 117
Gimsing, P., Carlson, K. E., Turesson, I., Fayers, P. M., Waage, A., Vangsted, A. J., Mylin, A. K., Gluud, C. N., Juliusson, G., Gregersen, H., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70198-4 · Cited by 117
Tosi, P., Zamagni, E., Cellini, C., Cangini, D., Tacchetti, P., Tura, S., Baccarani, M., & Cavo, M. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00272.x · Cited by 112
Self-citationManagement of older adults with multiple myeloma
Palumbo, A. P., & Mina, R. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.04.001 · Cited by 91
Self-citationEriksson, T., Höglund, P., Turesson, I., Waage, A., Don, B. R., Vu, J. T., Scheffler, M. R., & Kaysen, G. A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022241 · Cited by 89
Mohty, B., Cheikh, J. E., Yakoub‐Agha, I., Avet‐Loiseau, H., Moreau, P., & Mohty, M. (2011) · Leukemia · doi:10.1038/leu.2011.310 · Cited by 80
Self-citationPalumbo, A. P., Waage, A., Hulin, C., Beksaç, M., Zweegman, S., Gay, F., Gimsing, P., Leleu, X. P., Wijermans, P., Sucak, G. T., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.067058 · Cited by 76
Self-citationLudwig, H., Adam, Z., Tóthová, E., Hájek, R., Labar, B., Egyed, M., Špıčka, I., Gisslinger, H., Drach, J. W., Kühn, I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.020586 · Cited by 70
Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies ☆
Ho, T. W., Backonja, M. M., Ma, J., Leibensperger, H., Froman, S., & Polydefkis, M. J. (2008) · Pain · doi:10.1016/j.pain.2008.07.013 · Cited by 58
How to Manage Neutropenia in Multiple Myeloma
Palumbo, A. P., Bladé, J., Boccadoro, M., Palladino, C., Davies, F. E., Dimopoulos, M. A., Dmoszyńska, A., Einsele, H., Moreau, P., Sezer, O., et al. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.11.001 · Cited by 52
Self-citationAdvances in the biology and treatment of myeloma bone disease
Berenson, J. R. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70055-9 · Cited by 43
Niesvizky, R., Flinn, I. W., Rifkin, R. M., Gabrail, N. Y., Charu, V., Clowney, B., Essell, J. H., Gaffar, Y., Warr, T. A., Neuwirth, R. B., et al. (2011) · Blood · doi:10.1182/blood.v118.21.478.478 · Cited by 38
Self-citationMorabito, F., Gentile, M., Mazzone, C., Rossi, D., Raimondo, F. D., Bringhen, S., Ria, R., Offidani, M., Patriarca, F. F., Nozzoli, C., et al. (2011) · Blood · doi:10.1182/blood-2011-05-353995 · Cited by 35
Self-citationPalumbo, A. P., Bringhen, S., Rossi, D., Cavalli, M. M., Ria, R., Gentilini, S., Patriarca, F. F., Nozzoli, C., Levi, A., Guglielmelli, T., et al. (2012) · Blood · doi:10.1182/blood.v120.21.200.200 · Cited by 35
Self-citationAdvances in the biology and treatment of myeloma bone disease.
Berenson, J. R. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.34071 · Cited by 30
Mateos, M., López‐Corral, L., Hernández, M., Giraldo, P., de la Rubia, J., de Arriba, F., Rosiñol, L., Lahuerta, J. J., Palomera, L., Bargay, J., et al. (2010) · Blood · doi:10.1182/blood.v116.21.1935.1935 · Cited by 29
The troublesome toxicity of peripheral neuropathy with thalidomide
Mileshkin, L., & Prince, H. M. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600948303 · Cited by 28
Management of older patients with multiple myeloma
Gay, F., & Palumbo, A. P. (2011) · Blood Reviews · doi:10.1016/j.blre.2010.10.003 · Cited by 27
Self-citationRenal recovery with lenalidomide in a patient with bortezomib-resistant multiple myeloma
Ludwig, H., & Zojer, N. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.31 · Cited by 16
Touzeau, C., Blin, N., Clavert, A., Roland, V., Loirat, M., Tessoulin, B., Gouill, S. L., Planche, L., Pennetier, M., Mahé, B., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.654116 · Cited by 12
Self-citationMateos, M., Oriol, A., Teruel, A. I., Bengoechea, E., Pérez, M., López, J., Diaz‐Mediavilla, J., Hernández, J. M., de Arriba, F., Gonzalez, Y., et al. (2011) · Blood · doi:10.1182/blood.v118.21.477.477 · Cited by 10
Cited by
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
Facon, T., Kumar, S., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817249 · Cited by 1,045
Self-citationDiagnosis and Management of Multiple Myeloma: A Review
Cowan, A. J., Green, D. J., Kwok, M., Lee, S., Coffey, D. G., Holmberg, L. A., Tuazon, S., Gopal, A. K., & Libby, E. N. (2022) · JAMA · doi:10.1001/jama.2022.0003 · Cited by 1,029
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Self-citationSan-Miguel, J. F., Hungria, V. T. M., Yoon, S.-S., Beksac, M., Dimopoulos, M. A., Elghandour, A., Jedrzejczak, W. W., Günther, A., Nakorn, T. N., Siritanaratkul, N., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70440-1 · Cited by 791
Self-citationPalumbo, A., Bringhen, S., Mateos, M.-V., Larocca, A., Facon, T., Kumar, S. K., Offidani, M., McCarthy, P., Evangelista, A., Lonial, S., et al. (2015) · Blood · doi:10.1182/blood-2014-12-615187 · Cited by 775
Self-citation
Metadata
- Authors
- Palumbo, A., Rajkumar, S. V., San Miguel, J. F., Larocca, A., Niesvizky, R., Morgan, G., Landgren, O., Hajek, R., Einsele, H., Anderson, K. C., Dimopoulos, M. A., Richardson, P. G., Cavo, M., Spencer, A., Stewart, A. K., Shimizu, K., Lonial, S., Sonneveld, P., Durie, B. G. M., Moreau, P., & Orlowski, R. Z.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-02-20
- Volume
- 32
- Issue
- 6
- Pages
- 587-600
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2152124092
- Cited by
- 392
- References
- 118
- FWCI
- 28.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.